Old Web
English
Sign In
Acemap
>
Paper
>
Hydroxychloroquine (HCQ) use in G6PD deficient COVID-19 patients and the risk of Acute Hemeolytic Anaemia (AHA).
Hydroxychloroquine (HCQ) use in G6PD deficient COVID-19 patients and the risk of Acute Hemeolytic Anaemia (AHA).
2020
Sajad Ahmad Dar
Mohd Wahid
S Haque
Shaia Saleh R. Almalki
Naseem Akhter
Keywords:
Immunology
Hydroxychloroquine
2019 20 coronavirus outbreak
severe acute respiratory syndrome coronavirus 2
Coronavirus disease 2019
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]